Skip to main content

Table 2 Summary of hematology data; mean (SD), N = 8

From: Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations

Variable (reference range and units)a

Day

Group 1 (sham)

Group 2 (2 mg/kg)

Group 3 (6 mg/kg)

Group 4 (10 mg/kg)

P-value2

Treatment

White blood cell count (5.0–14.1 × 103/μL)

Pretest

12.25 (2.10)

12.81 (2.53)

15.81 (5.14)

13.88 (4.39)

0.2703

30

9.91 (0.95)

12.29 (2.72)

11.74 (2.51)

11.31 (1.71)

91

10.15 (1.80)

10.45 (1.36)

12.83 (2.69)

12.46 (3.96)

181

9.34 (2.25)

11.03 (4.63)

11.30 (1.81)

10.59 (1.99)

Red blood cell count (4.95–7.87 × 106/μL)

Pretest

7.079 (0.396)

7.344 (0.407)

6.994 (0.582)

6.935 (0.597)

0.7588

30

7.124 (0.570)

7.169 (0.677)

6.940 (0.492)

6.910 (0.357)

91

7.103 (0.411)

7.590 (0.701)

6.995 (0.448)

6.984 (0.534)

181

6.835 (0.380)

6.880 (0.538)

6.633 (0.389)

6.948 (0.289)

Reticulocytes (< 80 × 103/μL)

Pretest

42.70 (14.25)

51.36 (35.09)

45.20 (13.76)

42.90 (13.09)

0.0962

30

32.89 (14.74)

40.03 (16.68)

47.28 (16.49)

35.43 (12.29)

91

13.73 (8.39)

22.65 (9.31)

26.43 (15.38)

22.76 (8.48)

181

28.48 (24.78)

21.51 (8.90)

41.43 (18.70)

30.53 (15.87)

Eosinophils (0.0–1.3 × 103/μL)

Pretest

0.226 (0.062)

0.278 (0.179)

0.270 (0.097)

0.358 (0.102)

0.0005

30

0.248 (0.122)

0.265 (0.137)

0.291 (0.095)

0.453 (0.141)

91

0.228 (0.057)

0.274 (0.115)

0.288 (0.089)

0.465 (0.207)

181

0.276 (0.073)

0.301 (0.112)

0.340 (0.109)

0.598 (0.176)

Platelets (211–621 × 103/μL)

Pretest

333.5 (52.7)

311.9 (49.7)

269.3 (63.1)

300.3 (46.4)

0.8921

30

346.8 (81.4)

333.9 (36.1)

295.9 (90.0)

315.8 (37.3)

91

313.9 (62.7)

313.3 (61.6)

301.5 (68.4)

306.4 (54.4)

181

301.3 (84.0)

298.6 (63.8)

269.0 (90.2)

277.1 (41.5)

Hemoglobin (11.9–18.9 g/dL)

Pretest

15.54 (0.73)

15.70 (0.85)

15.49 (1.28)

15.04 (1.30)

0.8821

30

16.09 (1.00)

15.90 (1.02)

15.88 (1.13)

15.49 (1.20)

91

15.60 (0.66)

16.68 (1.35)

15.69 (1.00)

15.45 (1.26)

181

15.76 (0.79)

15.53 (1.21)

15.45 (0.92)

15.93 (0.61)

Hematocrit (35–57%)

Pretest

43.94 (2.12)

44.86 (2.46)

43.63 (3.66)

42.56 (3.51)

0.8776

30

45.11 (3.16)

44.45 (2.98)

44.31 (3.31)

43.20 (2.89)

91

44.05 (2.95)

46.68 (4.00)

43.66 (2.86)

42.63 (4.16)

181

42.65 (2.40)

42.53 (3.36)

41.71 (2.28)

43.19 (1.57)

  1. Footnote:
  2. a These reference ranges are to be used for information only and the pretest values collected before the dosing period during acclimatization should be used for interpretation in the context of this study
  3. 2 P-values in bold denote significance